The UK is leading the way, forming a network of advanced therapies treatment centres; joint ventures set up to include industry, academic and NHS partners and funded by Innovate UK. Cell and Gene Therapy Catapult are supporting the development of this network. Dr Jacqueline Barry, the Chief Clinical Officer at the CGT Catapult was interviewed by Phacilitate:Exchange about the future of patient access to therapies and how industry sectors will work together to improve delivery.
